Struthers Richard Scott bought CRNX
December 18, 2025 · Form 4 insider transaction
Struthers Richard Scott bought 28,400 shares of Crinetics Pharmaceuticals Inc at $15.29 per share, a transaction worth $434.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
28,400
Price
$15.29
Total value
$434.2K
InsiderStruthers Richard Scott
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 18, 2025
Filing dateDecember 18, 2025
Shares owned after364,759
OwnershipDirect
10b5-1 planNo
AmendedNo